Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$573M |
| 2 |
Microsoft
MSFT
|
+$529M |
| 3 |
McDonald's
MCD
|
+$469M |
| 4 |
Walt Disney
DIS
|
+$303M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$291M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$482M |
| 2 |
Comcast
CMCSA
|
+$481M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$381M |
| 4 |
Sherwin-Williams
SHW
|
+$374M |
| 5 |
CELG
Celgene Corp
CELG
|
+$341M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.22% |
| 2 | Technology | 7.41% |
| 3 | Consumer Discretionary | 6.04% |
| 4 | Financials | 5.89% |
| 5 | Industrials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
Allstate
ALL
$56.6B
| $88.4M | 0.08% |
1,084,762
+370,040
| +52% | +$29.1M |
2013 Q2
15 quarters
|
|
|
CSC
227
DELISTED
Computer Sciences
CSC
| $87.3M | 0.08% |
1,264,462
-592,744
| -32% | -$39.3M |
2013 Q2
15 quarters
|
|
228
CALL
Starbucks
SBUX
$108B
| $87M | 0.08% |
1,489,600
+441,800
| +42% | +$25M |
2013 Q2
15 quarters
|
|
229
CALL
Visa
V
$677B
| $86.5M | 0.08% |
973,500
+178,700
| +22% | +$15.4M |
2013 Q2
15 quarters
|
|
230
CALL
Caterpillar
CAT
$389B
| $85.8M | 0.08% |
924,900
+148,100
| +19% | +$14M |
2013 Q2
15 quarters
|
|
231
Lincoln National
LNC
$7.72B
| $85M | 0.08% |
1,298,514
-459,996
| -26% | -$31.5M |
2013 Q2
15 quarters
|
|
|
SNV
232
DELISTED
Synovus
SNV
| $84.7M | 0.08% |
2,065,376
-274,449
| -12% | -$11.4M |
2013 Q2
15 quarters
|
|
233
PUT
Johnson & Johnson
JNJ
$617B
| $84.6M | 0.08% |
679,300
-164,700
| -20% | -$19.7M |
2013 Q2
15 quarters
|
|
|
234
Sherwin-Williams
SHW
$77.6B
| $84.3M | 0.08% |
814,938
-3,710,607
| -82% | -$374M |
2014 Q4
9 quarters
|
|
235
Norfolk Southern
NSC
$71.3B
| $84.2M | 0.08% |
752,401
-306,347
| -29% | -$35.8M |
2015 Q4
5 quarters
|
|
236
Arrow Electronics
ARW
$12.3B
| $84.2M | 0.08% |
1,147,096
+1,132,520
| +7,770% | +$82.9M |
2016 Q4
1 quarter
|
|
237
CALL
AutoZone
AZO
$45.2B
| $82.9M | 0.08% |
114,600
-4,900
| -4% | -$3.63M |
2013 Q2
15 quarters
|
|
238
CALL
CVS Health
CVS
$111B
| $82.2M | 0.08% |
1,047,400
-133,200
| -11% | -$10.6M |
2013 Q2
15 quarters
|
|
|
MON
239
CALL
DELISTED
Monsanto Co
MON
| $82.1M | 0.08% |
725,200
+35,700
| +5% | +$3.95M |
2013 Q2
15 quarters
|
|
240
PUT
Procter & Gamble
PG
$337B
| $81M | 0.07% |
901,300
-820,600
| -48% | -$72.8M |
2013 Q2
15 quarters
|
|
241
Owens Corning
OC
$9.36B
| $80.9M | 0.07% |
1,317,953
+1,135,442
| +622% | +$65.1M |
2014 Q1
12 quarters
|
|
242
L3Harris
LHX
$44.1B
| $80.2M | 0.07% |
721,075
+681,626
| +1,728% | +$72.9M |
2016 Q3
2 quarters
|
|
243
CALL
Walmart Inc
WMT
$827B
| $80M | 0.07% |
3,328,500
-1,942,800
| -37% | -$44.7M |
2013 Q2
15 quarters
|
|
244
PUT
Morgan Stanley
MS
$299B
| $80M | 0.07% |
1,866,700
+352,900
| +23% | +$15.7M |
2013 Q2
15 quarters
|
|
245
Altria Group
MO
$112B
| $79.7M | 0.07% |
1,116,180
+775,271
| +227% | +$56.1M |
2014 Q2
11 quarters
|
|
246
PUT
Regeneron Pharmaceuticals
REGN
$75.7B
| $79.6M | 0.07% |
205,300
+26,200
| +15% | +$9.71M |
2013 Q2
15 quarters
|
|
247
Expedia Group
EXPE
$31.8B
| $79.3M | 0.07% |
628,835
+292,779
| +87% | +$35.7M |
2013 Q2
15 quarters
|
|
248
Becton Dickinson
BDX
$48.2B
| $78.9M | 0.07% |
441,106
+401,322
| +1,009% | +$70M |
2013 Q2
15 quarters
|
|
249
PUT
Gilead Sciences
GILD
$179B
| $78.9M | 0.07% |
1,162,200
-88,900
| -7% | -$6.25M |
2013 Q2
15 quarters
|
|
|
TCF
250
DELISTED
TCF Financial Corporation
TCF
| $78.9M | 0.07% |
4,636,427
+3,098,094
| +201% | +$55M |
2015 Q1
8 quarters
|
|
Similar funds
Citadel Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, Citadel Advisors held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $4.43B of net new capital in Q1 2017, opening 1,445 new positions and adding to 2,647 existing holdings. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 63% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $482M trimmed.
- Citadel Advisors's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
- Citadel Advisors added most to Microsoft in Q1 2017, an estimated $529M increase.
- Citadel Advisors's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
- Citadel Advisors fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
- Citadel Advisors's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
- Citadel Advisors opened 1,445 new positions and closed 1,267 in Q1 2017.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $109B.
Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.